Evusheld neutralises Omicron in latest studies

Only antibody authorised in the US for pre-exposure prophylaxis of COVID-19

Sputnik Light booster after Sputnik V effective against Omicron: Study

Sputnik Light as a booster significantly increases virus neutralizing activity against Omicron based on sera 2-3 months after revaccination

2022: Predictions for medical and healthcare industry

2022 is going to be the year of opportunities and innovations from the medical industry in India

Moderna says Covid-19 booster dose works against Omicron in lab study

Authorized booster increases Omicron neutralizing antibody levels approximately 37-fold

Six benefits of Cloud Computing in the pharma industry

NephroPlus raises US $ 24 mn in E round to fund expansion

The current round is led by IIFL Asset Management (IIFL AMC) along with investment from existing investors InvestCorp and Bessemer Venture Partners (BVP)

Lo.Li Pharma International seeks partners for Deplesin therapy

Deplesin is an add-on therapy to gold standard agents like lithium, valproic acid, and carbamazepine, supporting patients in ways that prescription medications often cannot

HealthPlix releases Prescription Summary Dashboard for doctors

Doctors can now analyse their historical prescriptions within a few clicks enabling them to identify different cohorts of patients and the treatment given to them

Baxter acquires Hillrom for US $ 15 billion

It accelerates the company’s vision for transforming healthcare and advancing patient care worldwide – from the hospital to the home

Moderna to set up mRNA vaccine manufacturing facility in Australia

Up to 100 million mRNA vaccine doses could be produced in Australia each year